The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Olwill Shane since 2021.
This trader's CIK number is 1875416.
At the time of last reporting, Olwill Shane was the Chief Development Officer of Pieris Pharmaceuticals, Inc.. (stock ticker symbol PIRS).
Also see all insider trading activities at Pieris Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | PIRS | 0 | $0 | 38,400 | $194,880 | 38,400 | $58,368 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-08-30 | PIRS | Sale | 38,400 | 5.08 | 194,880 |
| 2021-08-30 | PIRS | Option Ex | 38,400 | 1.52 | 58,368 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Olwill Shane (Chief Development Officer of Pieris Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.